InvestorsHub Logo
Followers 23
Posts 2199
Boards Moderated 0
Alias Born 03/18/2013

Re: Chabojilo post# 26699

Friday, 04/18/2014 11:10:57 AM

Friday, April 18, 2014 11:10:57 AM

Post# of 426483
Agree; says alot about Vascepa, if your going to do a study and you want the best product, why not use the "best in class." I like Rosenman's comments, if this study works Thetis doesn't need to do an outcomes study to be able to market this Metformin EPA drug. Just have it available and they will come..... I have several friends who are diabetics. They could use this drug. I forgot to include this part on my justification letter. That Vascepa is beneficial for diabetics for leveling Glucose levels. Even though I don't have diabetes, it is becoming more prevalent in older Americans.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News